½ÃÀ庸°í¼­
»óǰÄÚµå
1342798

¼¼°èÀÇ º´¿ø ¿Ü°ú¿ë ¼Òµ¶Á¦ ½ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¿¹Ãø(2023-2030³â)

Global Hospital Surgical Disinfectant Market Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Value Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 140 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

º´¿ø¿ë ¿Ü°ú ¼Òµ¶Á¦ ½ÃÀåÀÇ ¼¼°è ¼ö¿ä´Â Á¶»ç ±â°£2023-2030³â CAGR 9.12%·Î, 2022³â 4¾ï 6,752¸¸ ´Þ·¯¿¡¼­ 2030³â¿¡´Â ¾à 10¾ï 2,551¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

º´¿ø¿ë ¼ö¼ú¿ë ¼Òµ¶Á¦´Â ÀÇ·á ºÐ¾ß¿¡¼­ Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù. À̵éÀº ¼ö¼ú±â±¸¸¦ ¸ê±ÕÇÏ´Â µ¥ »ç¿ëµÇ´Â º´¿ø ¼Ò¸ðǰÀ¸·Î ¼ö¼ú Áß¿¡ »ç¿ëµË´Ï´Ù. ÀÌ·¯ÇÑ ¼Òµ¶Á¦´Â ¼ö¼ú±â±¸¸¦ ±ú²ýÇÏ°Ô À¯ÁöÇÏ¿© °¨¿° À§ÇèÀ» ÁÙÀÔ´Ï´Ù. ¼ö¼ú¿ë ¼Òµ¶Á¦´Â º´¿ø³» °¨¿°ÀÇ À§ÇèÀ» ÁÙÀ̱â À§ÇØ »ç¿ëµË´Ï´Ù. ¼ö¼ú Åø¿Í ÀýÂ÷¸¦ ±ú²ýÇÏ°Ô À¯ÁöÇÏ°í ¿À¿° ¹°ÁúÀ» ÆÄ±«ÇÕ´Ï´Ù.

½ÃÀå ¿ªÇÐ :

º´¿ø³» °¨¿°ÀÇ °¡´É¼º°ú À§ÇèÀ» ÁÙÀ̱â À§ÇØ º´¿ø¿ë ¼ö¼ú¿ë ¼Òµ¶Á¦¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Àνİú Áö½ÄÀÇ Çâ»óµµ ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. »ç¶÷µéÀÇ °Ç°­¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ´õ ³ªÀº ÀÇ·á ¼­ºñ½º¸¦ Á¦°øÇϱâ À§ÇÑ ³ë·ÂÀÌ È°¹ßÇØÁö°í ÀÖ½À´Ï´Ù. º´¿ø¿¡¼­´Â ¿À¿°¹°Áú·ÎºÎÅÍ Àΰ£°ú ºñ»ý¹°À» º¸È£Çϱâ À§ÇØ ¼ö¼ú¿ë ¼Òµ¶Á¦°¡ ÇÊ¿äÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀº ¼¼°è º´¿ø¿ë ¼ö¼ú¿ë ¼Òµ¶Á¦ ½ÃÀå ¼ö¿ä ÀáÀç·ÂÀ» ³ôÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ ÀÌ Áö¿ªÀÇ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©´Â ¾ÈÀüÇϰí È¿°úÀûÀÎ °íǰÁú ÀÇ·á ¼­ºñ½º Á¦°øÀ» º¸ÀåÇϰí ÀÖÀ¸¸ç, ÀÌ·Î ÀÎÇØ Á¦Ç° ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

ÀÌ Á¶»ç º¸°í¼­´Â Porter's Five Forces ¸ðµ¨, ½ÃÀå ¸Å·Âµµ ºÐ¼® ¹× ¹ë·ùüÀÎ ºÐ¼®À» ´Ù·ì´Ï´Ù. ÀÌ·¯ÇÑ ÅøÀº ¾÷°èÀÇ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇÏ°í ¼¼°è ¼öÁØ¿¡¼­ °æÀïÀÇ ¸Å·ÂÀ» Æò°¡ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ ÀÌ·¯ÇÑ ÅøÀº ¼¼°è º´¿ø¿ë ¼ö¼ú¿ë ¼Òµ¶Á¦ ¼¼°è ½ÃÀå¿¡¼­ °¢ ºÎ¹®À» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. º´¿ø¿ë ¼ö¼ú¿ë ¼Òµ¶Á¦ »ê¾÷ÀÇ ¼ºÀå°ú Ãß¼¼´ÂÀÌ ¿¬±¸¿¡ ´ëÇÑ ÀüüÀûÀÎ Á¢±Ù ¹æ½ÄÀ» Á¦°øÇÕ´Ï´Ù.

Áö¿ªº° ºÐ¼® :

ÀÌ ¼½¼Ç¿¡¼­´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ º´¿ø¿ë ¼ö¼ú¿ë ¼Òµ¶Á¦ ½ÃÀåÀÇ ÇöÀç ¹× ¹Ì·¡ ¼ö¿ä¸¦ °­Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ì´Ï´Ù. ¶ÇÇÑ ÀÌ º¸°í¼­´Â ¸ðµç ÁÖ¿ä Áö¿ªÀÇ °³º° ¿ëµµ ºÎ¹® ¼ö¿ä, ÃßÁ¤ ¹× ¿¹Ãø¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù.

¸ÂÃãÇü ¿ä±¸»çÇ×ÀÌ ÀÖ´Â °æ¿ì, ¹®ÀÇÇØÁֽñ⠹ٶø´Ï´Ù. ¸®¼­Ä¡ÆÀÀÌ °í°´ÀÇ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü º¸°í¼­¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå ÇÏÀ̶óÀÌÆ®
  • ¼¼°è ½ÃÀå ½º³À¼ô

Á¦3Àå º´¿ø¿ë ¿Ü°ú ¼Òµ¶Á¦ - »ê¾÷ ºÐ¼®

  • ¼­·Ð : ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ¾÷°è µ¿Çâ
  • Porter's Five Forces ºÐ¼®
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

  • ¹ë·ùüÀÎ ºÐ¼®
  • ¿øÀç·á ºÐ¼®
    • ¿øÀç·á ¸®½ºÆ®
    • ¿øÀç·á Á¦Á¶¾÷ü ¸®½ºÆ®
    • ÁÖ¿ä ¿øÀç·áÀÇ °¡°Ý µ¿Çâ
  • ÀáÀçÀû ¹ÙÀÌ¾î ¸®½ºÆ®
  • ¸¶ÄÉÆÃ Ã¤³Î
    • ´ÙÀÌ·ºÆ® ¸¶ÄÉÆÃ
    • ÀδÙÀÌ·ºÆ® ¸¶ÄÉÆÃ
    • ¸¶ÄÉÆÃ Ã¤³Î ¹ßÀü µ¿Çâ

Á¦5Àå COVID-19 ¹ß»ýÀÇ ¿µÇ⠺м®

Á¦6Àå ¼¼°èÀÇ º´¿ø¿ë ¿Ü°ú ¼Òµ¶Á¦ ½ÃÀå ºÐ¼® : Á¦Ç°º°

  • Á¦Ç°º° °³¿ä
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • Á¦Ç°º° ºÐ¼®
  • ¾ËÄÚ¿Ã
  • Ŭ·Î¸£Çí½Ãµò
  • Æ÷ºñµ·¿ä¿Àµå
  • ¿ÁÅ״ϵò
  • °ú»êÈ­¼ö¼Ò
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ º´¿ø¿ë ¿Ü°ú ¼Òµ¶Á¦ ½ÃÀå ºÐ¼® : ÃÖÁ¾ ¿ëµµº°

  • ÃÖÁ¾ ¿ëµµº° °³¿ä
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • ÃÖÁ¾ ¿ëµµº° ºÐ¼®
  • º´¿ø
  • Ŭ¸®´Ð
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ º´¿ø¿ë ¿Ü°ú ¼Òµ¶Á¦ ½ÃÀå ºÐ¼® : Áö¿ªº°

  • Áö¿ªº° Àü¸Á
  • ¼­·Ð
  • ºÏ¹Ì ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ºÏ¹Ì : ºÎ¹®º°
    • ºÏ¹Ì : ±¹°¡º°
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • À¯·´ : ºÎ¹®º°
    • À¯·´ : ±¹°¡º°
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ºÎ¹®º°
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ±¹°¡º°
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä« ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ¶óƾ¾Æ¸Þ¸®Ä« : ºÎ¹®º°
    • ¶óƾ¾Æ¸Þ¸®Ä« : ±¹°¡º°
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • Æä·ç
    • Ä¥·¹
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ºÎ¹®º°
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±¹°¡º°
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå º´¿ø¿ë ¿Ü°ú ¼Òµ¶Á¦ ±â¾÷ÀÇ °æÀï ±¸µµ

  • º´¿ø¿ë ¿Ü°ú ¼Òµ¶Á¦ ½ÃÀå °æÀï
  • Á¦ÈÞ/Çù·Â/ÇÕÀÇ
  • ÇÕº´¡¤Àμö
  • ½ÅÁ¦Ç° ¹ß¸Å
  • ±âŸ °³¹ß

Á¦10Àå ±â¾÷ °³¿ä

  • »óÀ§ ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
  • ½ÃÀå ÁýÁßµµ
  • 3M
  • Ecolab
  • BD
  • Sage Products LLC
  • B. Braun Melsungen AG
  • Johnson & Johnson
  • Kimberly-Clark Corporation
  • Cardinal Health
  • The Clorox Company
  • Schulke & Mayr GmbH
KSA 23.10.10

The global demand for Hospital Surgical Disinfectant Market is presumed to reach the market size of nearly USD 1025.51 MN by 2030 from USD 467.52 MN in 2022 with a CAGR of 9.12% under the study period 2023 - 2030.

Hospital surgical disinfectants are utilized in the medical field. These are hospital consumables used to sterilize surgical instruments and are used during surgery. These disinfectants reduce the risk of infection by keeping the surgical equipment clean. Surgical disinfectants are used to lower the risk of hospital-acquired illnesses. These keep the surgical instrument and procedure clean and destroy contaminants

MARKET DYNAMICS:

To reduce the possibility and danger of hospital-acquired infections, the demand for hospital surgical disinfectants has scaled up. The rise in awareness and knowledge has also impacted market growth. People are becoming more health-conscious and making more efforts to ensure better healthcare solutions. In hospitals, surgical disinfectants are required to keep humans and non-living things free of contaminants; these factors are anticipated to boost demand possibilities in the worldwide hospital surgical disinfectant market. Additionally, the regulatory framework in the area guarantees the provision of high-quality healthcare services that are both safe and effective, thus enhancing the demand of the product.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of hospital surgical disinfectant. The growth and trends of hospital surgical disinfectant industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the hospital surgical disinfectant market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Alcohols
  • Chlorhexidine
  • Povidone-Iodine
  • Octenidine
  • Hydrogen Peroxide
  • Others

By End-Use

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Hospital Surgical Disinfectant market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the hospital surgical disinfectant market include 3M, Ecolab, BD, Sage Products LLC, B. Braun Melsungen AG, Johnson & Johnson, Kimberly-Clark Corporation, Cardinal Health, The Clorox Company, Schulke & Mayr GmbH. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . HOSPITAL SURGICAL DISINFECTANT - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By End-Use
    • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL HOSPITAL SURGICAL DISINFECTANT MARKET ANALYSIS BY PRODUCT

  • 6.1 Overview by Product
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product
  • 6.4 Alcohols Historic and Forecast Sales by Regions
  • 6.6 Chlorhexidine Historic and Forecast Sales by Regions
  • 6.5 Povidone-Iodine Historic and Forecast Sales by Regions
  • 6.7 Octenidine Historic and Forecast Sales by Regions
  • 6.8 Hydrogen Peroxide Historic and Forecast Sales by Regions
  • 6.9 Others Historic and Forecast Sales by Regions

7 . GLOBAL HOSPITAL SURGICAL DISINFECTANT MARKET ANALYSIS BY END-USE

  • 7.1 Overview by End-Use
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by End-Use
  • 7.4 Hospitals Historic and Forecast Sales by Regions
  • 7.5 Clinics Historic and Forecast Sales by Regions
  • 7.6 Ambulatory Surgical Centers Historic and Forecast Sales by Regions
  • 7.7 Others Historic and Forecast Sales by Regions

8 . GLOBAL HOSPITAL SURGICAL DISINFECTANT MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2. North America By Segment Sales Analysis
    • 8.3.3. North America By Country Sales Analysis
    • 8.3.4. United State Sales Analysis
    • 8.3.5. Canada Sales Analysis
    • 8.3.6. Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2. Europe by Segment Sales Analysis
    • 8.4.3. Europe by Country Sales Analysis
    • 8.4.4. United Kingdom Sales Analysis
    • 8.4.5. France Sales Analysis
    • 8.4.6. Germany Sales Analysis
    • 8.4.7. Italy Sales Analysis
    • 8.4.8. Russia Sales Analysis
    • 8.4.9. Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2. Asia Pacific by Segment Sales Analysis
    • 8.5.3. Asia Pacific by Country Sales Analysis
    • 8.5.4. China Sales Analysis
    • 8.5.5. India Sales Analysis
    • 8.5.6. Japan Sales Analysis
    • 8.5.7. South Korea Sales Analysis
    • 8.5.8. Australia Sales Analysis
    • 8.5.9. Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2. Latin America by Segment Sales Analysis
    • 8.6.3. Latin America by Country Sales Analysis
    • 8.6.4. Brazil Sales Analysis
    • 8.6.5. Argentina Sales Analysis
    • 8.6.6. Peru Sales Analysis
    • 8.6.7. Chile Sales Analysis
    • 8.6.8. Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2. Middle East & Africa by Segment Sales Analysis
    • 8.7.3. Middle East & Africa by Country Sales Analysis
    • 8.7.4. Saudi Arabia Sales Analysis
    • 8.7.5. UAE Sales Analysis
    • 8.7.6. Israel Sales Analysis
    • 8.7.7. South Africa Sales Analysis
    • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE HOSPITAL SURGICAL DISINFECTANT COMPANIES

  • 9.1. Hospital Surgical Disinfectant Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF HOSPITAL SURGICAL DISINFECTANT INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. 3M
    • 10.3.1. Company Overview
    • 10.3.2. Company Revenue
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. Ecolab
    • 10.4.1. Company Overview
    • 10.4.2. Company Revenue
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. BD
    • 10.5.1. Company Overview
    • 10.5.2. Company Revenue
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. Sage Products LLC
    • 10.6.1. Company Overview
    • 10.6.2. Company Revenue
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. B. Braun Melsungen AG
    • 10.7.1. Company Overview
    • 10.7.2. Company Revenue
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. Johnson & Johnson
    • 10.8.1. Company Overview
    • 10.8.2. Company Revenue
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. Kimberly-Clark Corporation
    • 10.9.1. Company Overview
    • 10.9.2. Company Revenue
    • 10.9.3. Products
    • 10.9.4. Recent Developments
  • 10.10. Cardinal Health
    • 10.10.1. Company Overview
    • 10.10.2. Company Revenue
    • 10.10.3. Products
    • 10.10.4. Recent Developments
  • 10.11. The Clorox Company
    • 10.11.1. Company Overview
    • 10.11.2. Company Revenue
    • 10.11.3. Products
    • 10.11.4. Recent Developments
  • 10.12. Schulke & Mayr GmbH
    • 10.12.1. Company Overview
    • 10.12.2. Company Revenue
    • 10.12.3. Products
    • 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦